✦ LIBER ✦

ErbB tyrosine kinase receptor inhibitors in breast cancer treatment

✍ Scribed by Joan Albanell Mestres; Montserrat Muñoz Mateo; Pedro Gascón

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ErbB1/2 tyrosine kinase inhibitor mediat

✍ Katherine M. Aird; Jennifer L. Allensworth; Ines Batinic-Haberle; H. Kim Lyerly; 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 557 KB

Tyrosine kinase inhibitors in cancer the

✍ Srinivasan Madhusudan; Trivadi S. Ganesan 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 518 KB

EGRF-CD533 acts as a PAN-ERBB receptor t

✍ J.N Contessa; A Abell; G Lammering; T Hewit; K Valerie; R.K Schmidt-Ullrich 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 27 KB

A randomized, phase II, dose-finding stu

✍ Olivier Rixe; Sandra X. Franco; Denise A. Yardley; Stephen R. Johnston; Miguel M 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 367 KB

Type I Receptor Tyrosine Kinases as Targ

✍ José Baselga; John Mendelsohn 📂 Article 📅 1997 🏛 Springer US 🌐 English ⚖ 1022 KB

ZNF217, a candidate breast cancer oncoge

✍ Krig, S R; Miller, J K; Frietze, S; Beckett, L A; Neve, R M; Farnham, P J; Yaswe 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 692 KB